A randomized phase II trial of irinotecan in combination with infusional or two different bolus 5-fluorouracil and folinic acid regimens as first-line therapy for advanced colorectal cancer

K. Bouzid, S. Khalfallah, Jerzy Tujakowski, Béla Pikó, Gunta Purkalne, Signe Plāte, Peeter Padrik, Magdy El Serafy, E.M. Pshevloutsky, B. Boussard

Annals of Oncology · 2003 · 21 citations · 16 references

DOIFull text

Open access

Concepts

References

16